Innospec Inc. (IOSP) 12-Month Stock Forecast & Price Target Cone

$99.89 -1.50% NASDAQ • Live Quote vs Prior Daily Close (Synced Snapshot) EXT / AFTER-HRS: $99.43

Innospec Inc. (IOSP) carries a Roarable Rating of C+ (Hold) with 69/100 RQD Confidence. The composite score sits in the neutral Hold band (59–69), meaning current holders don’t need to panic-sell while prospective buyers can wait for a move into the 70+ Buy zone.

ROARABLE C+ • HOLD / WATCH Cap $2.46B
📤 Share Live RQD Speedometer Card: 𝕏 Post Reddit StockTwits ⬇ Live SVG Card
⚡ INSTANT AI QUANT PREVIEW • $0 FREE TIER Click Any Pre-Computed AI Quant Specialist Briefing on IOSP Below — or Connect Your Own ChatGPT / Claude
🤖 Mara Quenwick • AI Quant Lead (Click for Instant Brief) Is IOSP stock a Buy, Hold, or Sell right now according to Roarable's RQD model?
▼

As of 2026-11-03, Innospec Inc. (NASDAQ: IOSP) is rated C+ (Hold / HOLD) by Roarable's 5-pillar RQD engine with a composite confidence score of 69/100 at a spot price of $99.89 (-1.50% 1D, market cap $2.46B). Pillar breakdown: Fundamental Cash Engine 14/20, Institutional 13F & Options Flow 16/20, Executive Insider Alignment 14/20, FRED Macro Regime Fit 12/20, and SEC Balance-Sheet Forensics 13/20. Across 270 tracked Materials issuers, IOSP ranks #11 in composite RQD confidence.

✓ Pre-computed one-to-many AI Quant brief
🤖 Ellis Vennor • AI Peer & Flow Quant (Click for Instant Brief) How does IOSP compare to NGVT and ROG in the Materials sector?
▼

Within the Materials sector (Major Chemicals), IOSP carries a Roarable C+ (69/100 RQD), trailing P/E of N/A, gross margin of 27.7%, and ROIC of 9.9%. By comparison, NGVT (Ingevity Corporation) holds a C+ grade (66/100 RQD, P/E N/A, ROIC 85.0%, cap $2.55B) and ROG (Rogers Corporation) posts a D grade (48/100 RQD, P/E N/A, ROIC -3.6%, cap $2.37B). Among the 5-stock peer group, WDFC leads on earnings multiple (32.3x) while NGVT leads on capital efficiency (85.0% ROIC).

✓ Pre-computed one-to-many AI Quant brief
🤖 Gideon Ashmere • AI SEC 10-K Forensics (Click for Instant Brief) What are the biggest fundamental strengths and SEC risk factors for IOSP?
▼

Per IOSP's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-12-31, CIK 0001054905), Innospec Inc. generated $1.78B in revenue (-3.7% YoY), $0 in net income, and $138.3M in free cash flow against $1.83B in total assets and $0 in total debt. Key quantitative strengths: Big institutional funds and options desks are actively positioning on the bullish side.. Primary risk factors monitored: Broader market pullbacks can still drag down strong stocks in the short run.. Institutional options positioning shows a 50% call / 50% put premium split.

✓ Pre-computed one-to-many AI Quant brief
🤖 AI Quant Disclosure: Roarable Analysts are proprietary AI Quant Specialists — not human financial advisors. Pre-computed one-to-many briefings above are free; interactive 1-on-1 Q&A, custom AI sifting/indicator alerts, and personal ChatGPT/Claude MCP connections require a $9.95/mo Pro account (currently waitlist-only).
INTERACTIVE SCENARIO DECK:
🛡️ Portfolio Crash X-Ray
EXT / AFTER-HRS: $99.43 (-0.46%)🧬 Cannibal Buyback (-1.52% YoY Shares)⚙️ Cash Engine: 14/20 (B-) • 7.8% FCF Margin
Verify 90D Bucket Audit →
📊 Historical Track Record: Scores of 69/100 (C+) historically posted market-perform odds over rolling 90-day windows (+2.0% avg 90D alpha vs SPY • 57.3% hit rate — wait for RQD ≥ 70 breakout).
Audit Bucket Track Record →
RQD QUANT TACHOMETERHOLD / WATCH • C+
025507510069
3-of-3 JEV AI Jury Bullish
Cash
SEC
Whale

Impersonal quantitative research (0–100 RQD rubric) — not individualized investment advice. Past performance does not guarantee future results. Full Disclaimer

5-PILLAR SNOWFLAKE RADARRw B · Rk C
Cash (14)Whales (16)SEC (14)Macro (12)CEO (13)
Each axis scored 0–20
12M PRICE TARGET CONE+4.9% Base Target
$124 Bull$105 Base$82 Bear
📬 FREE IOSP RATING-CHANGE & BRIEFING ALERTSManage / Unsubscribe
WHALE OPTIONS SNAPSHOT: — (No Active Options Snapshot on file for IOSP)Realized 20D OHLCV Swing Band: ±3.9%
Deterministic 5-Pillar Attribution (69/100 Composite)
🔍 WHY IOSP SCORES 69/100 (C+) — TOP 3 DRIVERS2 Bullish Pillars + #1 Risk Drag
▲ #1 Bullish Driver: Whale & Options Positioning+16/20 pts (23% of score)

20D Institutional Volume Accumulation (±3.9% realized swing band)

▲ #2 Bullish Driver: Cash Engine Quality+14/20 pts (20% of score)

SEC XBRL FY 2025 (10-K): 7.8% FCF Margin ($138.3M FCF) & 27.7% Gross Margin

▼ #1 Drag / Risk Factor: Macro Regime Fit12/20 pts (-8 pt drag)

Macro rate sensitivity & RSI-14 (57) create a -8 pt regime headwind

📈 PAST 4 QUARTERS RQD vs SUBSEQUENT RETURNQ1 → Q2 → Q3 → Current
Q1 (-3Q)
61
Grade C$97.43+1.8% Next Q
Q2 (-2Q)
64
Grade C+$99.16+0.8% Next Q
Q3 (-1Q)
66
Grade B-$99.92+0% Next Q
Current
69
Grade C+$99.89+2% Hist 90D α
Trajectory: C (61) → C+ (69)Full Audit →
⚔️ ADVERSARIAL OPPOSING CASE & FORENSIC KILL-SWITCH (WHY THE BULL/BEAR THESIS COULD FAIL)GIDEON ASHMERE // FORENSIC SHORT & KILL-SWITCH DOSSIER

⚔️ Adversarial Opposing Case: Why the IOSP Bull Thesis Could Fail

Gideon Ashmere Forensic Desk →

Even with a 69/100 (C+) score, IOSP faces multiple-compression risk if current valuation multiples re-rate toward historical sector medians or if hyperscaler/enterprise customer concentration slows in upcoming 10-Q filings.

⚠️ Forensic Kill-Switch #1

Broader market pullbacks can still drag down strong stocks in the short run.

⚠️ Forensic Kill-Switch #2

Dilution & Margin Drag: Cannibal Buyback (-1.52% YoY Shares) — any gross margin slip below 25.2% triggers an automatic RQD downgrade.

⚠️ Forensic Kill-Switch #3

Technical & Forensic Kill-Switch: A daily close below the 50D SMA ($96.29) or 200D SMA ($84.57) invalidates the momentum regime and cuts Target Base ($104.83) toward Bear Floor ($81.77).

🎲 LIVE PREDICTION MARKET ODDS TIED TO $IOSP• $2.4M Crowd Pool • Kalshi / Polymarket Composite
Contract: “IOSP Beats Next Quarter EPS Consensus (Dec 30, 2026) & Holds Above 200D SMA”
INTERACTIVE 12-MONTH POSITION SIMULATOR

Drag to Test Your IOSP Position Size: $10,000

Shares at $99.89: 100.1 sh
$1,000$10,000$25,000$50,000$100,000
12M Bear Case FloorTarget $81.77
$8,186
$-1,814 (-18.1%)
12M Consensus BaseTarget $104.83
$10,495
+$495 (+4.9%)
12M Bull Case BreakoutTarget $123.70
$12,384
+$2,384 (+23.8%)

Wall Street Analyst Breakdown & Historical Accuracy Audit (28 Desks)

Street Historical Accuracy: 64/100
● Strong Buy / Buy: 17● Hold: 9● Sell: 2
Wall Street FirmStance12M Target1Y AccuracyTrack Grade
Morgan StanleyInstitutional Equity DeskHOLD$10974%A
Goldman SachsSector Coverage LeadBUY$11669%B
JP MorganUS Large-Cap ResearchHOLD$9358%C
ON-DEMAND RQD QUANT WORKSHOP • SPONSORED / PARTNER SPOTLIGHTHosted by Perry Belcher & Roarable Quantitative Research Desk

Scheduled RQD Strong Buys & Whale Accumulation Briefing (IOSP Tape Review)

  • ✓Breakdown of the highest-scoring RQD Green-Light breakouts across our 5,200+ rated universe
  • ✓Forensic Red-Light accounting & dilution traps to review on your watchlist
  • ✓Includes downloadable .ics calendar invite & nightly RQD rating-change email alerts
RQD INSIDER CLUB WAITLIST$49/YR PLANNED
Want Custom AI PineScript / Python Indicators & Priority Rating-Change Alerts?
IOSP // CANDLESTICK & AUTO-TRENDLINE WORKSTATION6M: +30.61%▲ ASCENDING CHANNEL
2026-11-03O $101.4H $101.4L $99.89C $99.89VOL 216.5K
RES: $105.1SUP: $87.59SMA50: $96.29SMA200: $84.57
$104.0$95.77$87.56$79.34$71.13RES $105.1SUP $87.59$99.892026-05-042026-06-172026-08-042026-09-182026-11-03
PRIMARY-SOURCE FORENSICS, SECOND-ORDER LINKS & AI ANALYST DESK

IOSP Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure

Share Count & Dilution Monitor (#25)

Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).

Reverse-DCF Expectations Hurdle (#30)
14.9%/yr Implied 5Y Growth

vs. -3.7% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).

Ellis Vennor Setup Ledger (#33)

No active Ellis Vennor swing setup published on IOSP today. View full Setup Ledger →

🦋 Documented & Second-Order Butterfly Connections Open Graph →

No direct multi-tier Butterfly edges indexed yet for IOSP. Explore sector supply chains on /butterfly.

AI Analyst Theses, Washington Policy & Company Video
🎬 No recent verified company-specific video clip queued for IOSP today (we never pad ticker pages with unrelated generic clips). Browse Macro Video Desk →
DETERMINISTIC MULTI-FACTOR EQUITY AUDIT • SEC EDGAR XBRL × RQD PEER BENCHMARK

📊 Quantitative Sector Peer Comparison, SEC Filing Delta & Investment FAQ (IOSP)

Materials Rank #11 of 270 ⚔️ NGVT vs IOSP Full Matrix →

1. Head-to-Head Materials Peer Comparison (IOSP vs. NGVT, ROG, KWR, WDFC)

Industry: Major Chemicals (67 Tracked Issuers)

Across 270 tracked Materials securities in the Roarable RQD universe, Innospec Inc. (IOSP) ranks #11 by composite RQD confidence (69/100, grade C+) and #103 by equity capitalization ($2.46B). Within this direct 5-issuer industry benchmark cohort, WDFC leads on earnings valuation at 32.3x trailing P/E, while NGVT leads on capital efficiency and profitability with 85.0% ROIC and 39.5% gross margin. WDFC currently holds the highest overall quantitative score in the immediate peer group at 73/100 (B) compared with IOSP at 69/100 (C+).

Ticker / Company Roarable Grade RQD Score Trailing P/E Gross Margin ROIC 1D Change Market Cap Head-to-Head
IOSP ACTIVE
Innospec Inc.
C+ 69/100 — 27.7% 9.9% -1.50% $2.46B Benchmark Subject
NGVT
Ingevity Corporation
C+ 66/100 — 39.5% 85.0% -1.39% $2.55B /ngvt-vs-iosp →
ROG
Rogers Corporation
D 48/100 — 31.7% -3.6% -5.18% $2.37B /rog-vs-iosp →
KWR
Quaker Houghton
D 46/100 — 36.0% 2.1% -4.38% $2.60B /kwr-vs-iosp →
WDFC
WD-40 Company
B 73/100 32.3x 55.1% 27.2% +0.55% $2.95B /wdfc-vs-iosp →

2. Multi-Year SEC XBRL Revenue, Cash Flow & Balance-Sheet Trajectory (FY2023–FY2025)

SEC EDGAR 10-K • FILED 2025-12-31 • CIK 0001054905

In its most recent audited fiscal period (FY2025, filed 2025-12-31), Innospec Inc. (IOSP) reported GAAP revenue of $1.78B (-3.7% vs. FY2024 revenue of $1.85B , and -8.8% cumulative change since FY2023) , GAAP net income of $0, operating cash flow of $138.3M, and free cash flow of $138.3M (-25.0% YoY). On the balance sheet, IOSP closed FY2025 with $1.83B in total assets against $0 in total debt (Altman Z-Score: 5.47, Piotroski F-Score: 4/9).

Fiscal Period Filing Date Revenue Net Income Operating Cash Flow Free Cash Flow Total Assets Total Debt
FY2025 (FY) 2025-12-31 $1.78B $0 $138.3M $138.3M $1.83B —
FY2024 (FY) 2024-12-31 $1.85B $0 $184.5M $184.5M $1.73B —
FY2023 (FY) 2023-12-31 $1.95B $0 $207.3M $207.3M — —

3. IOSP Data-Verified Investor FAQ (RQD Rating, Sector Peers, SEC Forensics & Technicals)

✓ SCHEMA.ORG FAQPAGE JSON-LD ENABLED

Is IOSP stock a Buy, Hold, or Sell right now according to Roarable's RQD model?

As of 2026-11-03, Innospec Inc. (NASDAQ: IOSP) is rated C+ (Hold / HOLD) by Roarable's 5-pillar RQD engine with a composite confidence score of 69/100 at a spot price of $99.89 (-1.50% 1D, market cap $2.46B). Pillar breakdown: Fundamental Cash Engine 14/20, Institutional 13F & Options Flow 16/20, Executive Insider Alignment 14/20, FRED Macro Regime Fit 12/20, and SEC Balance-Sheet Forensics 13/20. Across 270 tracked Materials issuers, IOSP ranks #11 in composite RQD confidence.

How does IOSP compare to NGVT and ROG in the Materials sector?

Within the Materials sector (Major Chemicals), IOSP carries a Roarable C+ (69/100 RQD), trailing P/E of N/A, gross margin of 27.7%, and ROIC of 9.9%. By comparison, NGVT (Ingevity Corporation) holds a C+ grade (66/100 RQD, P/E N/A, ROIC 85.0%, cap $2.55B) and ROG (Rogers Corporation) posts a D grade (48/100 RQD, P/E N/A, ROIC -3.6%, cap $2.37B). Among the 5-stock peer group, WDFC leads on earnings multiple (32.3x) while NGVT leads on capital efficiency (85.0% ROIC).

What are the biggest fundamental strengths and SEC risk factors for IOSP?

Per IOSP's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-12-31, CIK 0001054905), Innospec Inc. generated $1.78B in revenue (-3.7% YoY), $0 in net income, and $138.3M in free cash flow against $1.83B in total assets and $0 in total debt. Key quantitative strengths: Big institutional funds and options desks are actively positioning on the bullish side.. Primary risk factors monitored: Broader market pullbacks can still drag down strong stocks in the short run.. Institutional options positioning shows a 50% call / 50% put premium split.

Where is IOSP trading relative to its 50-day, 200-day, and 52-week technical levels?

IOSP last traded at $99.89 (-1.50% on volume of 216,494 shares), positioning the stock +3.74% above its 50-day simple moving average ($96.29) and +18.12% above its 200-day simple moving average ($84.57). Across its 52-week range of $65.51 to $102.00, IOSP sits at the 94.2% percentile with a 14-day RSI of 57.0 (BULLISH MOMENTUM) and an implied next-earnings move of ±3.9% ($95.99 to $103.79).

IOSP Investor FAQ & Complete 8-Part Research Index

100% OPEN ACCESS • SEC EDGAR × CBOE × FRED

What is IOSP's 12-month stock price target?

Innospec Inc. (IOSP) carries a 12-month consensus base price target of $104.83 (+4.9% from $99.89), with a bull-case target of $123.7 and a bear-case floor of $81.77.

Is IOSP stock a Buy, Hold, or Sell right now?

Roarable's 5-Pillar RQD Quant Engine rates IOSP C+ (Hold — HOLD) with an RQD Confidence score of 69/100.

ROARABLE RATING BRIEF • RQD 69/100 (C+) ✓ STAGE-C NUMBER FIREWALL VERIFIED

IOSP — Innospec Inc.: What the Facts Mean to a Prospective Investor

Engine: anthropic/claude-haiku-5.5
As of: 2026-11-02T15:25:31Z

Roarable Rating Brief: What This Means to a Prospective Investor

Per the Roarable RQD rating, IOSP scores 70 out of 100 with a letter grade of B- and a verdict of "Roarable Buy — Sound Institutional Accumulation." The five pillars are: Fundamental Cash Engine at 14/20 (ROIC 9.9%; FCF yield 5.54%), Whale 13F Flow at 16/20 (institutional accumulation and options positioning), Insider Conviction at 13/20 (SEC Form 4 and Congressional PTR cluster flow), Macro Regime Fit at 13/20 (beta 1.0; sector sensitivity), and Forensic Balance Sheet at 14/20 (Altman Z 5.47; Piotroski F 4/9; Debt/Equity 0.5). The strongest pillar is institutional flow, while insider conviction and macro fit sit lower. For a prospective investor, the upside case rests on the cash-generation and balance-sheet pillars combined with accumulation signals. The valuation tradeoff is that the shares trade at an EV/EBITDA of 17 with a 5.54% FCF yield, and the source data does not provide P/E or EPS to frame earnings-based valuation. The rating is a source-derived scoring output, not a recommendation to act.

Business

Innospec Inc. is a NASDAQ-listed issuer in the Materials sector, operating within the Major Chemicals industry, per the Profile section. The source data does not describe its products, customers, or revenue model beyond the sector classification. The Snapshot and Financial Trend sections show reported revenue of $1778.0M for FY 2025, but the source data does not explain how the company earns that revenue.

Financial Trend

PeriodRevenueOperating IncomeNet IncomeEPSFCFCashDebt
FY 2025$1778.0M$129.5M$0.0MN/A$138.3M$292.5MN/A
FY 2024$1845.4M$177.9M$0.0MN/A$184.5M$289.2MN/A
FY 2023$1948.8M$161.6M$0.0MN/A$207.3MN/AN/A

Per the SEC financials, revenue declined across the three reported periods, and operating income fell from $177.9M in FY 2024 to $129.5M in FY 2025. Reported net income is $0.0M in each period and EPS is N/A. Per the market data, gross margin is 27.7%, operating margin 7.3%, and net margin 0%. ROIC is 9.9%. Per the RQD forensic pillar, Altman Z is 5.47, Piotroski F is 4/9, and Debt/Equity is 0.5. Cash was $292.5M in FY 2025, and the source data does not provide debt figures.

Recent Catalysts & News Wire Analysis

The news wire lists six items, all tagged to IOSP, from Yahoo Finance, TradingView, Simply Wall St, Benzinga, and Stock Traders Daily. Headlines reference stock forecasts, estimates ahead of an upcoming earnings release, a report that the stock could be 25% undervalued despite steady cash flow, a Q2 2026 earnings call transcript, and rotational strategy timing. Each item carries a YELLOW light and a MARKET WIRE impact label. The summaries are generic and do not contain specific figures. Per the Butterfly Supply-Chain Graph, the supply chain is NONE, with no butterfly links and no proprietary signals. Risk watch items are not specified in the source data beyond the general statement that the earnings release is upcoming.

Open Questions

  • What are IOSP's reported debt and EPS figures, which the financials leave as N/A or unreported, and how do they affect the forensic and valuation assessment?
  • What drove the decline in revenue and operating income across FY 2023 through FY 2025?
  • What is the basis for the 25% undervaluation claim referenced in the news wire, and what cash flow assumptions does it rely on?
  • What are the company's products, customers, and principal sources of revenue?
  • What do the upcoming earnings expectations specifically imply for the next reporting period?

IOSP Live News Feed, Press Releases & Catalyst Wire

Real-time company headlines, analyst actions, and sector developments for Innospec Inc. (IOSP) • Click "Debate This Headline" to argue it in the Roar Pit below

💬 Jump to IOSP Debate Forum (3) ↓
🟢 CATALYST Yahoo • 4d ago
Olin (OLN) Q3 Earnings Beat Estimates

Olin (OLN) delivered earnings and revenue surprises of +40.00% and -2.63%, respectively, for the quarter ended September 2026. Do the numbers hold clues to what lies ahead for the stock?

Read Full Source ↗
🔥 THE ROAR PIT • LIVE COMMUNITY DEBATE 3 Active Posts & Replies

IOSP Bull vs. Bear Conversation Board — What's Your Call at $99.89?

🐂 67% BULLISH CONVICTION COMMUNITY TUG-OF-WAR ON IOSP 🐻 33% BEARISH CONVICTION
1. Pick Your Side on IOSP:
💡 Tip: Back up your call with a price target or RQD metric to get upvoted to the top.
RO RoarDesk_Moderator Roarable Research Desk 🐂 BULLISH 🎯 Target: $119.66 (+18.0%)
📌 Pinned Debate

🔥 Official Bull vs. Bear Debate: Is IOSP (B- • RQD 70/100) a Buy at $101.41?

Welcome to the IOSP (Innospec Inc.) Roar Pit. Current RQD Composite is 70/100 (Roarable Buy — Sound Institutional Accumulation) in Major Chemicals. Bulls point to operating leverage and sector positioning, while bears focus on macro rate sensitivity and margin execution. Pick your side (🐂 Bull or 🐻 Bear) and drop your price target below.

VA ValDiscipline Forensic Accounting Watch 🐻 BEARISH 🎯 Target: $79.10 (-22.0%)
Spot @ $101.41

Pump the brakes on IOSP — check the valuation vs. margin headwinds

Everyone in here is repeating the bull case on IOSP, but look at what you are paying: current EV/EBITDA multiples with 27.7% gross margins. Unless Innospec Inc. expands free cash flow yield next quarter, I would rather wait for a pullback closer to the 200-day moving average before touching this.

MI MidwestValue Verified K Arena Trader 🐂 BULLISH 🎯 Target: $126.76 (+25.0%)
Spot @ $101.41

IOSP cash flow & RQD setup is being underpriced by the Street here

Looking at the 5-pillar RQD breakdown on IOSP, the market is fixating on short-term headline noise in Major Chemicals and ignoring the balance sheet and cash flow trajectory. At $101.41 (52-wk range $65.51 - $102.00), any beat on forward guidance forces shorts and underweight funds to chase.

LIVE TAPE SPY $752.10 -1.80% QQQ $681.09 -3.60% DIA $519.34 -1.08% IWM $279.14 -1.68% NVDA $204.64 -4.22% AAPL $344.63 -1.23% MSFT $521.91 -1.55% TSLA $399.81 -0.86% PLTR $184.11 -6.27% SOFI $16.76 -4.83% IBIT $43.35 -5.42% GLD $361.65 -3.59%